Merck & Co., Inc. - May 7, 2021 Form 3 Insider Report for Organon & Co. (OGN)

Role: 10%+ Owner
Signature: Merck & Co., Inc. /s/ Kelly E.W. Grez, Deputy Corporate Secretary
Stock symbol: OGN
Transactions as of: May 7, 2021
Transactions value $: $0
Form type: 3
Date filed: 5/7/2021, 05:02 PM
Next filing: Jun 4, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	OGN	Common Stock						100	May 7, 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 3 is being filed in connection with the Securities and Exchange Commission's declaration of effectiveness of the Registration Statement on Form 10 of Organon & Co. ("Organon"), which describes the separation of Organon from Merck & Co., Inc.